These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3126407)

  • 21. Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids.
    Zaccara G; Boncinelli L; Paganini M; Campostrini R; Arnetoli G; Zappoli R
    Acta Neurol Scand; 1983 Oct; 68(4):241-7. PubMed ID: 6419536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valproic acid-induced hyperammonemia and minimal hepatic encephalopathy prevalence among psychiatric inpatients.
    Thomas KL; La AQ; Punia S; Doroudgar S; Perry PJ
    Ann Clin Psychiatry; 2016 Feb; 28(1):37-42. PubMed ID: 26855984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sodium valproate: a hyperammonemic drug. Study in the epileptic and healthy volunteer].
    Marescaux C; Warter JM; Laroye M; Rumbach L; Micheletti G; Koehl C; Imler M; Kurtz D
    J Neurol Sci; 1983 Feb; 58(2):195-209. PubMed ID: 6403673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.
    Gupta S; Rogers LK; Taylor SK; Smith CV
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):317-27. PubMed ID: 9344900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for valproic acid induced hyperammonemia and its association with cognitive functions.
    Duman B; Can KC; Ağtaş-Ertan E; Erdoğan S; İlhan RS; Doğan Ö; Kumbasar H; Çamsarı UM
    Gen Hosp Psychiatry; 2019; 59():67-72. PubMed ID: 31276904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salicylate potentiates valproate-induced hyperammonemia in the rat.
    Uetrecht JP
    Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of valproate and citrulline on ammonium-induced encephalopathy.
    Stephens JR; Levy RH
    Epilepsia; 1994; 35(1):164-71. PubMed ID: 8112241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Biochem Pharmacol; 1988 Jun; 37(11):2255-8. PubMed ID: 3132174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
    Yamamoto H; Sugihara N
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.
    Suzuki K; Matsuo N; Moriguchi T; Takeyama N; Kitazawa Y; Tanaka T
    Metab Brain Dis; 1992 Jun; 7(2):63-75. PubMed ID: 1528171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion.
    Warter JM; Marescaux C; Hirsch E; Rumbach L; Micheletti G; Chabrier G; Imler M
    J Neurol Sci; 1985 Jul; 69(3):285-90. PubMed ID: 3928824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
    Mallet L; Babin S; Morais JA
    Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbamyl phosphate synthetase deficiency and postpartum hyperammonemia.
    Kotani Y; Shiota M; Umemoto M; Tsuritani M; Hoshiai H
    Am J Obstet Gynecol; 2010 Jul; 203(1):e10-1. PubMed ID: 20471629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnitine for valproic acid-induced hyperammonemia.
    Raby WN
    Am J Psychiatry; 1997 Aug; 154(8):1168-9. PubMed ID: 9247410
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
    Yamamoto HA; Sugihara N
    Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gait instability in valproate-treated patients: Call to measure ammonia levels.
    Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
    Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose ethanol prevents propionate induced hyperammonemia.
    Stewart PM; Walser M
    Biochem Biophys Res Commun; 1981 Jun; 100(4):1430-5. PubMed ID: 7295308
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of acute valproate administration on carnitine metabolism in mouse serum and tissues.
    Rozas I; Camiña MF; Paz JM; Alonso C; Castro-Gago M; Rodriguez-Segade S
    Biochem Pharmacol; 1990 Jan; 39(1):181-5. PubMed ID: 2105093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures.
    Gal P; Oles KS; Gilman JT; Weaver R
    Neurology; 1988 Mar; 38(3):467-71. PubMed ID: 3126410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.